Candriam Equities L Biotech.I GBP Acc/ LU1269737059 /
| NAV6/1/2023 | Chg.-16.7500 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 3,113.9199GBP | -0.54% | reinvestment | Equity Worldwide | Candriam ▶ |
Monthly performance
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2016 | - | - | - | 1.64 | 6.04 | -0.12 | 13.33 | -1.09 | 4.68 | -6.72 | 6.19 | -1.75 | - |
| 2017 | 3.79 | 8.04 | -0.55 | -2.13 | -2.82 | 8.54 | 1.05 | 8.83 | -3.11 | -5.36 | -1.59 | 1.59 | +16.06% |
| 2018 | 1.61 | -1.63 | -3.64 | -1.30 | 8.37 | 1.78 | 5.19 | 5.17 | -2.34 | -12.18 | 4.36 | -8.08 | -4.56% |
| 2019 | 9.61 | 2.35 | 1.48 | -4.90 | -1.46 | 8.35 | 1.42 | -1.75 | -5.56 | 5.58 | 11.94 | 0.07 | +28.66% |
| 2020 | -4.76 | 2.04 | -2.16 | 10.91 | 11.53 | 1.46 | -8.51 | -1.07 | 4.34 | -2.82 | 6.39 | 0.66 | +17.29% |
| 2021 | 1.42 | -4.25 | -2.92 | 2.44 | -4.49 | 9.25 | -2.01 | 5.05 | -2.18 | -1.72 | -0.76 | -0.59 | -1.63% |
| 2022 | -9.93 | -1.98 | 7.73 | -3.11 | -3.70 | 6.91 | 4.41 | 5.70 | 2.20 | 3.71 | 2.65 | -3.74 | +9.66% |
| 2023 | 0.63 | -4.09 | -1.65 | 0.61 | 0.20 | -0.54 | - | - | - | - | - | - | - |
Calculated values
| YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
|---|---|---|---|---|---|
| Volatility | 18.73% | 19.44% | 23.64% | 22.82% | 24.46% |
| Sharpe ratio | -0.79 | -0.78 | 0.61 | -0.10 | 0.16 |
| Best month | +0.63% | +0.63% | +6.91% | +9.25% | +11.94% |
| Worst month | -4.09% | -4.09% | -4.09% | -9.93% | -12.18% |
| Maximum loss | -10.16% | -10.94% | -11.70% | -23.19% | -23.19% |
| Outperformance | -3.11% | - | -0.37% | - | - |
All quotes in GBP
Tranches
| Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
|---|---|---|---|---|---|
| Candriam Equities L Biotech.V US... | reinvestment | 1,856.3500 | +18.38% | +5.02% | |
| Candriam Equities L Biotech.C EU... | reinvestment | 201.8900 | +17.84% | - | |
| Candriam Equities L Biotech.I EU... | reinvestment | 1,899.3700 | +14.16% | -1.75% | |
| Candriam Equities L Biotech.I EU... | reinvestment | 2,019.0800 | +17.44% | +9.03% | |
| Candriam Equities L Biotech.I GB... | reinvestment | 3,113.9199 | +17.82% | +3.87% | |
| Candriam Equities L Biotech.R GB... | reinvestment | 326.5100 | +19.38% | +6.55% | |
| Candriam Equities L Biotech.R EU... | reinvestment | 295.2100 | +18.88% | +10.71% | |
| Candriam Equities L Biotech.R CH... | reinvestment | 189.2400 | +14.30% | -1.68% | |
| Candriam Equities L Biotech.V2 U... | reinvestment | 1,657.3500 | +19.89% | - | |
| Candriam Equities L Biotech.I US... | reinvestment | 5,060.2002 | +16.35% | +4.18% | |
| Candriam Equities L Biotech.V US... | reinvestment | 546.7500 | +18.12% | +2.35% | |
| Candriam Equities L Biotech.C EU... | reinvestment | 182.9900 | +15.31% | -2.40% | |
| Candriam Equities L Biotech.R US... | reinvestment | 239.5300 | +17.75% | +5.67% | |
| Candriam Equities L Biotech.R EU... | reinvestment | 189.2300 | +15.60% | -0.08% | |
| Candriam Equities L Biotech.C US... | reinvestment | 764.7400 | +18.61% | +3.75% | |
| Candriam Equities L Biotech.C US... | paying dividend | 702.7000 | +18.58% | +3.65% |
Performance
| YTD | -4.83% | ||
|---|---|---|---|
| 6 Months | -6.00% | ||
| 1 Year | +17.82% | ||
| 3 Years | +3.87% | ||
| 5 Years | +42.02% | ||
| 10 Years | - | ||
| Since start | +107.59% | ||
| Year | |||
| 2022 | +9.66% | ||
| 2021 | -1.63% | ||
| 2020 | +17.29% | ||
| 2019 | +28.66% | ||
| 2018 | -4.56% | ||
| 2017 | +16.06% | ||